Ranbaxy labs gets FDA nod for Cefadroxil oral suspension USP
Ranbaxy Laboratories has received approval from US Food and Drug Administration (FDA) to market Cefadroxil Powder for Oral Suspension USP in 125 mg/5 ml, 250 mg/5 ml and 500 mg/5 ml strengths. The